imipramine has been researched along with Brachmann-De Lange Syndrome in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| O'Neil, M | 1 |
| Page, N | 1 |
| Adkins, WN | 1 |
| Eichelman, B | 1 |
1 other study available for imipramine and Brachmann-De Lange Syndrome
| Article | Year |
|---|---|
Tryptophan-trazodone treatment of aggressive behaviour.
Topics: Adult; Aggression; De Lange Syndrome; Drug Therapy, Combination; Humans; Imipramine; Male; Trazodone | 1986 |